Christopher J. Sobecki's Insider Trades & SAST Disclosures
Christopher J. Sobecki's most recent trade in Lexicon Pharmaceuticals Inc was a trade of 36,810 Restricted Stock Units done . Disclosure was reported to the exchange on May 13, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Christopher J. Sobecki.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Lexicon Pharmaceuticals Inc | Christopher J. Sobecki | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 May 2025 | 36,810 | 0 | - | - | Restricted Stock Units | |
| Lexicon Pharmaceuticals Inc | Christopher J. Sobecki | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 May 2025 | 36,810 | 203,865 (0%) | 0% | 0 | Common Stock | |
| Lexicon Pharmaceuticals Inc | Christopher J. Sobecki | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2024 | 44,906 | 44,906 | - | - | Stock Option (Right to Buy) | |
| Lexicon Pharmaceuticals Inc | Christopher J. Sobecki | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2024 | 36,810 | 36,810 | - | - | Restricted Stock Units | |
| Lexicon Pharmaceuticals Inc | Christopher J. Sobecki | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Apr 2024 | 8,032 | 167,055 (0%) | 0% | 0 | Common Stock | |
| Lexicon Pharmaceuticals Inc | Christopher J. Sobecki | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Apr 2024 | 8,032 | 0 | - | - | Restricted Stock Units | |
| WW International Inc | Christopher J. Sobecki | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 May 2023 | 2,053 | 109,954 (0%) | 0% | - | Common Stock | |
| WW International Inc | Christopher J. Sobecki | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 May 2023 | 2,053 | 0 | - | - | Deferred Stock Unit | |
| WW International Inc | Christopher J. Sobecki | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2023 | 1,353 | 107,901 (0%) | 0% | 0 | Common Stock | |
| Lexicon Pharmaceuticals Inc | Christopher J. Sobecki | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 May 2023 | 9,302 | 159,023 (0%) | 0% | 0 | Common Stock | |
| Lexicon Pharmaceuticals Inc | Christopher J. Sobecki | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 May 2023 | 9,302 | 0 | - | - | Restricted Stock Units | |
| Lexicon Pharmaceuticals Inc | Christopher J. Sobecki | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Apr 2023 | 12,658 | 12,658 | - | - | Stock Option (Right to Buy) | |
| Lexicon Pharmaceuticals Inc | Christopher J. Sobecki | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Apr 2023 | 8,032 | 8,032 | - | - | Restricted Stock Units | |
| WW International Inc | Christopher J. Sobecki | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Apr 2023 | 2,053 | 2,053 | - | - | Deferred Stock Unit | |
| WW International Inc | Christopher J. Sobecki | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2023 | 5,067 | 106,548 (0%) | 0% | 0 | Common Stock | |
| WW International Inc | Christopher J. Sobecki | Director | Purchase of securities on an exchange or from another person at price $ 4.17 per share. | 17 Nov 2022 | 30,000 | 101,481 (0%) | 0% | 4.2 | 125,124 | Common Stock |
| WW International Inc | Christopher J. Sobecki | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 4,595 | 71,481 (0%) | 0% | 0 | Common Stock | |
| WW International Inc | Christopher J. Sobecki | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jul 2022 | 2,745 | 66,886 (0%) | 0% | 0 | Common Stock | |
| Lexicon Pharmaceuticals Inc | Christopher J. Sobecki | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2022 | 14,402 | 14,402 | - | - | Stock Option (Right to Buy) | |
| Lexicon Pharmaceuticals Inc | Christopher J. Sobecki | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2022 | 9,302 | 9,302 | - | - | Restricted Stock Units | |
| Lexicon Pharmaceuticals Inc | Christopher J. Sobecki | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Apr 2022 | 4,024 | 149,721 (0%) | 0% | 0 | Common Stock | |
| Lexicon Pharmaceuticals Inc | Christopher J. Sobecki | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Apr 2022 | 4,024 | 0 | - | - | Restricted Stock Units | |
| WW International Inc | Christopher J. Sobecki | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2022 | 1,797 | 64,141 (0%) | 0% | 0 | Common Stock | |
| WW International Inc | Christopher J. Sobecki | Director | Grant, award, or other acquisition of securities at price $ 15.90 per share. | 03 Jan 2022 | 1,179 | 62,344 (0%) | 0% | 15.9 | 18,746 | Common Stock |
| WW International Inc | Christopher J. Sobecki | Director | Grant, award, or other acquisition of securities at price $ 18.78 per share. | 04 Oct 2021 | 998 | 61,165 (0%) | 0% | 18.8 | 18,742 | Common Stock |
| WW International Inc | Christopher J. Sobecki | Director | Grant, award, or other acquisition of securities at price $ 35.84 per share. | 05 Jul 2021 | 523 | 60,167 (0%) | 0% | 35.8 | 18,744 | Common Stock |
| Lexicon Pharmaceuticals Inc | Christopher J. Sobecki | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2021 | 6,475 | 6,475 | - | - | Stock Option (Right to Buy) | |
| Lexicon Pharmaceuticals Inc | Christopher J. Sobecki | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2021 | 4,024 | 4,024 | - | - | Restricted Stock Units | |
| Lexicon Pharmaceuticals Inc | Christopher J. Sobecki | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Apr 2021 | 10,638 | 0 | - | - | Restricted Stock Units | |
| Lexicon Pharmaceuticals Inc | Christopher J. Sobecki | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Apr 2021 | 10,638 | 151,397 (0%) | 0% | 0 | Common Stock | |
| WW International Inc | Christopher J. Sobecki | Director | Grant, award, or other acquisition of securities at price $ 30.77 per share. | 05 Apr 2021 | 609 | 59,644 (0%) | 0% | 30.8 | 18,739 | Common Stock |
| WW International Inc | Christopher J. Sobecki | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2021 | 724 | 59,035 (0%) | 0% | 0 | Common Stock | |
| WW International Inc | Christopher J. Sobecki | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Sep 2020 | 996 | 58,311 (0%) | 0% | 0 | Common Stock | |
| WW International Inc | Christopher J. Sobecki | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jun 2020 | 740 | 57,315 (0%) | 0% | 0 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges